Pricing Log in Create free account
Saturday 17 October 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

285.42 2.02 +0.71%
Market cap
$500.8B
P/E
80.6×
Fwd P/E
27.8×
Dividend yield
2.42%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

AbbVie Inc. (ABBV) Current ratio

Alert me on Current ratio

AbbVie Inc.'s current ratio at the end of the quarter to 30 June 2026 was 0.8×, up 0.1× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.7× (fiscal 2024) to 3.2× (fiscal 2019); the current reading is higher than 18% of that period. That is below the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 0.7× 1.68%
FY2024 0.7× (24.30%)
FY2023 0.9× (9.50%)
FY2022 1.0× 21.44%
FY2021 0.8× (5.92%)
FY2020 0.8× (73.46%)
FY2019 3.2× 223.27%
FY2018 1.0× (22.93%)
FY2017 1.3× (22.94%)
FY2016 1.7× 10.51%

Quarterly newest first

Period Current ratio Change
Jun 2026 0.8× 1.52%
Mar 2026 0.8× 18.64%
Dec 2025 0.7× (7.34%)
Sep 2025 0.7× (1.54%)
42 more quarters

Against its own ten years

Low 0.7× High 3.2×
Ten-year median 1.0×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
AMGN Amgen Inc. compare 1.4×
LLY Eli Lilly and Company compare 1.4×
MRK Merck & Co., Inc. compare 1.3×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
JNJ Johnson & Johnson compare 1.1×
AZN AstraZeneca PLC compare 0.9×
NVS Novartis AG compare 0.9×
ABBV AbbVie Inc. 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on ABBV